[Intratumor BCG immunotherapy of advanced malignant melanoma].
D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D008297:Male; D008545:Melanoma / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*
D001500:BCG Vaccine
Próba immunoterapii doguzowej BCG chorych na zaawansowanego czerniaka złośliwego.